This is the raw data of Immunofluorescence in Met-5A cell. حسب Yangyang Yin (14323701)

الموضوعات:

Decrease in circulating iNKT cell activation during regadenoson (RA) infusion into patients with COVID-19. حسب Joseph Rabin (7399436)

الموضوعات:

Comparison of the decrease of CFU in CSF and blood between treatment groups within the first 6 h after treatment. حسب Luca G. Valente (12463057)

JBPOS0101 decreased Amyloid Beta (Aβ) aggregates in the cortex and hippocampal regions in 5xFAD mouse brains. حسب Jihoon Jeong (4852690)

This is the raw data of Western blot in Met-5A cell. حسب Yangyang Yin (14323701)

الموضوعات:

<i>Aspergillus flavus</i> mRNA expression (a) <i>aflD</i> and (c) <i>aflR</i> and phylogenetic analysis of (b) <i>aflD</i> and (d) <i>aflR</i> after exposure to 50 mg/mL of <i>U. e... حسب Martha Cebile Jobe (21175426)

Fig 5 - حسب Dalia Zaafar (6693017)

TBEV-induced translational arrest results in the decreased protein levels of GAPDH, HPRT1, and viperin. حسب Martin Selinger (3195987)

Fig 5 - حسب Andrea R. Thurman (5286005)

TUNEL staining of testis tissues. حسب Cao Wang (1500691)

الموضوعات:

Oxidative stress (OS) responses in the testis tissues. حسب Cao Wang (1500691)

الموضوعات:

Expression of ApoB-50 decreased lipid accumulation and inhibited HCV production. حسب Bei Wang (116772)

MiR-132-3p was downregulated in TGF-<i>β</i>1 stimulated Met-5A cells and miR-132-3p mimics and miR-132-3p inhibitor transfected Met-5A cells. حسب Yangyang Yin (14323701)

الموضوعات:

Does Mean Platelet Volume Decrease in the presence of Coronary Artery Fistula? حسب Isa Sincer (7234577)

"…<div><p>Abstract Background: Coronary artery fistula (CAF) is an abnormal connection that links a coronary artery to a cardiac chamber or another major blood vessel. …"

Flowchart of study selection. حسب Alejandro Piscoya (782326)

الموضوعات:

Description of characteristics of included studies. حسب Alejandro Piscoya (782326)

الموضوعات:

Effect of remdesivir on invasive ventilation at 14 days. حسب Alejandro Piscoya (782326)

الموضوعات:

Effect of remdesivir on all-cause mortality at 14 days. حسب Alejandro Piscoya (782326)

الموضوعات:

Summary of findings table for the comparison remdesivir 10 days vs. placebo for hospitalized, severe COVID-19. حسب Alejandro Piscoya (782326)

الموضوعات:

Summary of findings table for the comparison remdesivir 5 days vs. standard of care for hospitalized, moderate COVID-19. حسب Alejandro Piscoya (782326)

الموضوعات: